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Abstract 
Deciphering the control principles of metabolism and its interaction with other cellular 
functions is central to biomedicine and biotechnology. Yet, understanding the efficient 
control of metabolic fluxes remains elusive for large-scale metabolic networks. Existing 
methods either require specifying a cellular objective or are limited to small networks due to 
computational complexity. Here we develop an efficient computational framework for flux 
control by introducing a complete set of flux coupling relations. We analyze 23 metabolic 
networks from all kingdoms of life, and identify the driver reactions facilitating their control 
on a large scale. We find that most unicellular organisms require less extensive control than 
multicellular organisms. The identified driver reactions are under strong transcriptional 
regulation in Escherichia coli. In human cancer cells driver reactions play pivotal roles in 
tumor development, representing potential therapeutic targets. The proposed framework helps 
us unravel the regulatory principles of complex diseases and design novel engineering 
strategies at the interface of gene regulation, signaling, and metabolism.  
Introduction 
Understanding how cellular systems are controlled on a genome scale is a central issue in 
biology and medicine. Metabolic networks are at the center of systems biology approaches to 
unravel cellular control because metabolism carries the life-sustaining cellular functions 
shaping the molecular phenotype
1
. The steady-state principle and physico-chemical 
constraints (e.g. mass balance and thermodynamics) have been employed to reduce the 
number of considered network states, facilitating the prediction of genotype-phenotype 
relationships and intervention strategies for biotechnological or medical purposes
2
. In 
particular, flux balance analysis and variations thereof have been successfully applied to the 
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metabolic networks of unicellular organisms to predict their metabolic and cellular 
phenotypes
3
. Yet, those approaches are biased
4
, because they restrict the flux space to an a 
priori specified reference state by assuming a cellular objective to be optimized by the 
organism
5
. While optimization of biomass yield has proven useful for unicellular organisms, 
identification of a suitable objective for multicellular organisms remains a non-trivial 
endeavor
1
. Other approaches, e.g. elementary flux modes
6
 and extreme pathways analyses
7
, 
do not assume a cellular objective and hence are unbiased. However, despite extensive 
studies and recent advances
8
, these unbiased approaches are limited to rather small networks 
due to their computational complexity. It remains unclear how complex biological systems 
efficiently coordinate metabolism on a large scale. 
Here we develop a framework to systematically study the control principles of large-scale 
metabolic networks. The key idea is that the activity of a reaction can be controlled by 
directly manipulating a reaction to which it is coupled
9
. The most efficient control strategy is 
then given by the smallest set of driver reactions that must be directly controlled for 
controlling the activity of all reactions in the network at steady state. To reveal the smallest 
set of driver reactions offering control over the whole network, we first need to fully exploit 
all possible qualitative couplings among reactions. There are four possible cases by which the 
flux of one reaction R1 can be used to qualitatively control the flux of another reaction R2: (i) 
an active flux of R1 can activate R2; (ii) an inactive flux of R1 can deactivate R2; (iii) an 
inactive flux of R1 can activate R2; and (iv) an active flux of R1 can deactivate R2. We find 
that the flux coupling types proposed and widely used in literature only account for cases (i) 
and (ii), unaware of the potential offered by cases (iii) and (iv). Here we identify two new 
coupling types that describe well-known biochemical principles and allow us to consider the 
remaining two cases, eventually obtaining a complete set of qualitative coupling relations. 
We show that the driver reactions can be determined efficiently even for metabolic networks 
involving thousands of reactions by solving a classical graph-theoretic problem via integer 
linear programming. Our framework does not require any a priori knowledge of the cellular 
objectives, and hence is unbiased. It is also computationally efficient, facilitating, for the first 
time, systematic analyses of the control principles of large-scale metabolic networks and 
offering mechanistic insights into cellular regulation.  
Results 
A complete set of flux coupling relations enables efficient control of metabolic networks. 
Formally, the structure of a metabolic network is uniquely specified by its mn stoichiometric 
matrix, S=[sij], with m rows denoting metabolites and n columns representing reactions. An 
entry sij represents the molarity of metabolite i in reaction j, with negative entries denoting 
substrates and positive entries indicating products. A feasible flux distribution of a metabolic 
network S is defined as a flux vector v satisfying the steady-state condition (Sv=0) subject to 
lower and upper bounds (lbvub). We propose an additional constraint of a non-zero 
exchange of matter with the environment (i.e. the flux vi≠0 for at least one exchange reaction 
i). This is a natural requirement for any living system, which also allows us to introduce new 
flux coupling relations (see Methods). The status i
v
=|sign(vi)| of a reaction i in v is called 
active, if i
v
=1, and inactive, if i
v
=0. The aforementioned constraints imply that some 
reactions must operate in a concerted manner at steady state, leading to coupling relations 
between rates, and, thus, status of reactions. 
To represent the coupling relations between reactions in a metabolic network, we 
construct the flux coupling graph (FCG)
9
, where vertices denote reactions and edges describe 
the coupling types (Fig. 1a and Methods). Three types of flux coupling have been proposed in 
literature
9
: directional, partial, and full coupling. A reaction i is directionally coupled to j if 
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i
v
=1 implies that j
v
=1 (and equivalently, j
v
=0 implies i
v
=0) (e.g. R1 and R3 in Fig. 1a). 
Partial coupling is a special case of directional coupling: Two reactions, i and j, are partially 
coupled if they have the same status, i.e. i
v
=j
v
, in every feasible flux distribution (e.g. R2 
and R3 in Fig. 1a). Moreover, full coupling is a special case of partial coupling: two reactions 
are fully coupled, if there is a constant, ≠0, such that vi=vj for every feasible flux 
distribution v (e.g. R4 and R5 in Fig. 1a). Thus, full and partial coupling have equivalent 
implications with respect to the status of reactions i and j, since in both cases i
v
=1 if and 
only if j
v
=1. Moreover, these three coupling relations are similar in the sense that they allow 
a reaction to be activated or deactivated by imposing the same status on a reaction to which it 
is coupled (i
v
=j
v
). But they do not allow for activating or deactivating a reaction by using 
reactions that have a different status (i
v≠j
v
). Hence, they account only for two of the four 
possible cases of qualitative coupling, and consequently, do not provide a complete set of 
qualitative coupling relations (see Flux coupling analysis in Supplementary Methods).  
To consider the two remaining cases, we introduce two new coupling types, called anti- 
and inhibitive couplings: Two reactions i and j are anti-coupled, if at least one of i and j is 
active in any feasible flux distribution (i.e., i
v
=0 implies j
v
=1 and j
v
=0 implies i
v
=1, cf. 
R3 and R5 in Fig. 1a). A reaction i is inhibitively coupled to a reaction j if a maximum flux of 
reaction i implies that j is inactive. Note that just activating a reaction cannot imply the 
deactivation of another reaction (see Flux coupling analysis in Supplementary Methods). 
Inhibitive coupling accounts for the competition of coupled reactions for common substrates 
(e.g. R4 and R1 in Fig. 1a) or the accumulation of common products (e.g. R2 and R1 in Fig. 
1a). The two new coupling relations allow a reaction i to be activated or deactivated by using 
a reaction j which has a different status (i
v≠j
v
). Since the resulting five coupling types now 
account for each of the four possible cases of qualitative coupling between pairs of active or 
inactive reactions they offer a complete set of qualitative coupling relations.  
The coupling relations imply that reaction fluxes may not only be directly controlled by 
the regulation of enzyme activities and concentrations
10
, but also be implicitly controlled by 
the requirement of achieving and maintaining a steady state. This suggests that the expression 
of genes encoding the enzymes of coupled reactions is coordinated in agreement with their 
imposed status. For example, the synthesis of the enzyme catalyzing a reaction which is 
inactive due to its coupling with other reactions would imply a waste of resources. Likewise, 
if a reaction is required to be active due to the present couplings, but cannot occur based on 
the existing regulatory interactions, then the system cannot operate at steady state. Thus, we 
hypothesize that coupled reactions are co-regulated by a common transcription factor (TF). 
To test this hypothesis, we overlay the gene regulatory network of E. coli
11
 on its genome-
scale metabolic network
12
 and determine the agreement between reaction couplings and the 
co-regulation of their enzyme-coding genes by a common TF (see Methods). This generalizes 
a previous study of the operonic organization of genes associated with fully and directionally 
coupled reactions
13
, since TFs may regulate genes across operons. We find that coupled 
reactions are very likely co-regulated (hypergeometric test, p-value=3.3·10
-290
, including all 
types of coupling). With respect to the individual coupling types, there is a striking agreement 
between co-regulation and fully coupled reactions (Supplementary Fig. 2): while only 24,303 
(5.7%) of the total 427,350 pairs of enzyme-catalyzed reactions are co-regulated, 175 
(42.9%) of the 408 fully coupled pairs are co-regulated, which is highly significant 
(hypergeometric test, p-value=4.2·10
-105
). In contrast, none of the 36 partially coupled 
reaction pairs is co-regulated. There is a small, but significant (p-value=2.6·10
-2
) agreement 
for the 2,999 directionally coupled reactions, of which 196 are co-regulated (6.5%). This 
extends the finding that genes associated with fully and directionally coupled reactions are 
frequently located on the same operon
13
 and suggests their coordinated regulation by 
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common TFs. While there are no anti-coupled reactions in the genome-scale metabolic 
network of E. coli, the proposed inhibitive coupling also shows a strong agreement with co-
regulation: of the 6,847 inhibitively coupled reaction pairs, 1,220 are co-regulated (17.8%, p-
value=7.9·10
-278
). These results demonstrate that the expression of metabolic genes is 
coordinated by transcriptional regulation in line with reaction couplings, confirming their 
relevance for metabolic regulation. 
Flux coupling profiles capture phylogenetic signals of metabolic networks. To determine 
if the complete set of qualitative coupling relations reflects functional principles of 
metabolism, we analyze 23 high-quality metabolic networks from all kingdoms of life (Table 
1). The networks are selected based on their model quality, curation, and expert knowledge, 
and vary greatly in their sizes, tissues, subcellular compartmentalization, and uni- or 
multicellular organization. For each network, we first calculate the five coupling types over 
all reaction pairs. We find that anti-coupling is rarely found in genome-scale networks 
(Supplementary Table 1), which indicates the existence of redundant pathways operating in 
steady states of these networks (see Supplementary Methods). The relative frequencies of the 
five coupling types in a given network define the corresponding flux coupling profile (see 
Methods).  
To determine whether the flux coupling profiles reflect functionally important features of 
the analyzed metabolic networks, we assess their statistical significance using network 
randomization under mass-balance constraints
14
. We find that the flux coupling profiles for 
most networks and coupling types are significantly different from their randomized variants, 
suggesting that they reflect evolutionary features of their metabolism
15
 (see Methods). To 
determine the extent to which flux coupling profiles reflect the phylogeny of the considered 
biological systems, we apply three classical clustering algorithms together with three well-
established cluster quality measures (see Methods). The clustering of the flux coupling 
profiles indeed reveals the established phylogeny and functional differences of the metabolic 
networks, as demonstrated by the separation into five clusters obtained consistently from the 
three clustering algorithms (Fig. 2): the two flux coupling profiles of non-extremophile 
archaea (cluster 1) are separated from those of extremophiles (cluster 2) and the two networks 
of E. coli central metabolism (cluster 3). The flux coupling profiles of three cancer types fall 
together with the profiles of the genome-scale metabolic networks of E. coli and M. 
tuberculosis (cluster 4). Moreover, the cancer networks (clusters 2 and 4) are clearly 
separated from the corresponding healthy tissues (cluster 5), suggesting that distinct coupling 
patterns characterize healthy and cancer tissues. In particular, the flux coupling profiles of all 
9 considered eukaryotes form a separate branch of the clustering tree (cluster 5) despite the 
apparent differences in the size and cellular organization of the represented metabolic 
networks (cf. Table 1). 
The frequencies of different types of coupling thus allow us to distinguish functional 
features of metabolism (Fig. 2b-f): non-extremophile archaea (cluster 1) show a balance of 
full, partial, directional, and inhibitive couplings, while the metabolism of extremophiles 
(cluster 2) is dominated by directional couplings. The prevalence of full and inhibitive 
couplings in cluster 3 suggests a balance between tightly coupled and competing pathways in 
E. coli central metabolism. This is in contrast to its genome-scale metabolic network (cluster 
4), suggesting the prevalence of distinct coupling patterns in primary and secondary 
metabolism. Moreover, cluster 5 is dominated by inhibitive couplings, which suggests that 
competing pathways, a widespread feature of eukaryote metabolism due to gene and whole 
genome duplications
16
, are key to controlling these networks. By contrast, the lower 
frequency of inhibitive couplings in the metabolic networks of cancer cells (clusters 2 and 4) 
allows a clear distinction from the healthy tissue networks. 
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For comparison, we find that the clustering based only on the previously studied flux 
coupling types, i.e. full, partial, and directional couplings, does not correspond to 
phylogenetic or functional relationships of the analyzed metabolic networks (see Methods 
and Supplementary Fig. 3). Here, we observe that networks within functionally or 
phylogenetically related groups, such as the networks of E. coli central metabolism, 
extremophiles, or eukaryotes, are dispersed across clusters. Moreover, the separation of 
cancer networks from their corresponding healthy tissue networks is no longer apparent, 
since cancer networks are assigned to clusters together with the corresponding healthy tissue 
or other eukaryotic networks. This indicates that the flux coupling profiles obtained from the 
complete set of coupling types, but not those of the previously studied coupling types, reflect 
an intrinsic phylogenetic signal of metabolic networks. Finally, we find that the clustering 
based only on structural determinants (i.e. of the cumulative distribution of singular 
values
17,18
), yields few large clusters that are significantly different from those of the 
complete set of flux coupling profiles (adjusted Rand Index of -0.06, see Methods) and, too, 
lack correspondence to phylogenetic relationships. Hence, a characterization of the 
phylogenetic or functional requirements of these networks based only on their structural 
determinants is not obvious.  
Driver reactions are obtained by integrating flux coupling with activity patterns. Based 
on the complete set of qualitative coupling relations, we propose a comprehensive control 
framework to identify the smallest sets of driver reactions. Consider a reaction activity 
pattern ={0,1}n that describes the status of reactions in a given metabolic network at steady 
state (Fig. 1b-d). We can generate feasible activity patterns using two distinct sampling 
schemes (see Methods). For each feasible activity pattern, we determine its driver reactions as 
follows. First, we construct a control graph (CG) by integrating the FCG with the activity 
pattern: The CG contains a vertex for each reaction in the metabolic network and a directed 
edge (ij), if controlling the status of reaction i allows us to impose the status of reaction j in 
the activity pattern. For example, if reaction i is directionally coupled to reaction j, and 
i=j=1 according to the desired activity pattern, then the CG contains the directed edge (i, j), 
but not (j, i), as i can be used to activate j, but not necessarily vice versa (e.g. R1 and R2 in 
Fig. 1b, see Methods). Then a smallest set of driver reactions, denoted as D(CG), which must 
be directly controlled to impose the status of all reactions in the activity pattern, is just a 
smallest vertex set D in CG such that the union of D and its out-neighborhood N
+
(D) covers 
all vertices in CG, i.e. 
 (  )        {   (  )    
 ( )   (  )}. 
In graph theory, D(CG) is called a minimum out-dominating set
19
 of the CG, which can 
be exactly solved via an integer linear program (see Methods). Although in general the 
minimum out-dominating set problem is NP-hard
20
, we find that it is actually 
computationally inexpensive even for large networks with thousands of vertices (see Efficient 
calculation of driver reactions in Supplementary Discussion).  
To quantify the difficulty of qualitative flux control in metabolic networks, we calculate 
the average size of the smallest driver reaction sets over 1,000 feasible activity patterns. 
Inspection of the relationship between network size and the average number of driver 
reactions over different activity patterns indicates that the complexity of qualitative flux 
control scales linearly with the size of metabolic networks (Pearson correlation of 0.97, p-
value=3·10
–14
, Supplementary Fig. 4). However, when considering the fraction of driver 
reactions, we observe that the genome-scale metabolic networks of most prokaryotes require 
smaller fractions of drivers (15.5-43.4%), and, thus, are easier to control, in comparison to 
those of eukaryotes (35.8-49.2%). Moreover, it is more facile to control the considered 
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genome-scale metabolic networks than the smaller networks of central metabolism (15.5-
49.2% and 57.9-82.6%, respectively, see Fig. 3a). This finding is in line with the observation 
that, unlike primary metabolism, the pathways of secondary metabolism may be controlled by 
manipulating one or few enzymes
1
. 
In addition, we observe that the fraction of driver reactions follows a power-law decay 
with the fraction of coupled reactions (Fig. 3b, scaling coefficient of 0.24, Pearson correlation 
of –0.72 (log-log), p-value=1.2·10–4). On one hand, this finding suggests that structural 
modifications leading to few additional coupled reactions may substantially improve the 
control of metabolic networks that are otherwise difficult to control. On the other hand, this 
also indicates that the inclusion of additional coupled reactions has only a small impact on 
networks that have few driver reactions. These results are robust with respect to the choice of 
the sampling scheme and the number of sampled activity patterns (see Methods). Despite the 
finding that flux coupling analysis is sensitive to missing reactions
21
, we observe that the 
determined driver reactions are not significantly altered (Pearson correlation of driver 
frequencies, see Sensitivity to missing reactions in Supplementary Discussion) when 
removing up to 15% of the reactions from the network of E. coli central metabolism, or up to 
25% of the reactions from the genome-scale metabolic network. Altogether, these robustness 
tests demonstrate the power of our method in making predictions from incomplete network 
reconstructions
22
. 
Driver reactions are under strong transcriptional regulation. Since the key idea of our 
method is that driver reactions facilitate control of metabolic fluxes, we hypothesize that the 
enzyme-coding genes associated with driver reactions are under strong transcriptional 
regulation to achieve efficient control of metabolism. To test this hypothesis, we determine 
the number of TFs regulating the enzyme(s) associated with each reaction of the genome-
scale metabolic network of E. coli. Similar to the classification of vertices by their roles in 
controlling an arbitrary complex network
23
, we group the reactions in the metabolic network 
of E. coli into three classes depending on the number of activity patterns in which they appear 
as driver reactions: redundant reactions are never required for control and, thus, can always 
be controlled through other reactions; intermittent reactions are driver reactions for at least 
one, but not all considered activity patterns, and critical reactions are driver reactions for all 
activity patterns. We find that both critical and intermittent reactions are regulated by 
significantly more TFs (average of 1.9 and 2.9, respectively) in comparison to redundant 
reactions (average of 1.0, Wilcoxon rank sum test p-values of 1.3·10
–15
 and 2.1·10
–37
, 
respectively) (Fig. 4a). The large number of TFs associated with intermittent reactions 
indicates that reactions whose role as driver or non-driver varies for different activity patterns 
require the most extensive transcriptional regulation. In addition, we observe that fewer TFs 
than expected by chance (46 of 82) are associated with more than one class of reactions (Fig. 
4b, permutation test, p-value=10
–3
), suggesting that the three classes of reactions operate 
under distinct modes of transcriptional regulation. Moreover, of the TFs associated with more 
than one class, significantly more are shared between intermittent and critical reactions (34 of 
46) compared to the other intersections (30 TFs are shared between redundant and 
intermittent, and 24 between redundant and critical reactions; permutation test, p-value=2·10
–
3
), which points at the similarly important role of intermittent and critical driver reactions in 
transcriptional regulation, and attributes a less pronounced role to redundant reactions. 
Driver reactions control tumor development at the interface between gene regulation, 
signaling, and metabolism. The accelerated glucose uptake, glycolysis, and lipogenesis are a 
signature of proliferating cells in a variety of tumors, thought to arise through aberrant 
interactions between gene regulation, signaling pathways, and metabolism
24
. Indeed, we find 
that the four investigated networks of cancer metabolism have 65% (1,799/2,778) of reactions 
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in common (Supplementary Fig. 5a), suggesting the involvement of similar metabolic 
pathways. However, only 40% (300/742) of the critical driver reactions are shared among the 
four cancer types (Supplementary Fig. 5b). The discrepancy between the identified driver 
reactions is most pronounced for the lung and urothelial cancer models, which share 81% of 
reactions, but only 58% of their driver reactions. This suggests that the driver reactions may 
reveal control principles of different types of cancer beyond their universal metabolic 
requirements.  
To determine if the identified driver reactions are related to genes known to cause 
cancer
25
, we rely on the gene-enzyme-reaction associations. Remarkably, we find that critical 
driver reactions in the four cancer networks are frequently associated to cancer causing genes 
(hypergeometric test, p-value=6.8·10
–4
), suggesting that our framework can be used to 
identify reactions whose causal role in cancer is hitherto unknown. In contrast to previous 
analyses that compare the presence and absence of reactions in cancer vs. healthy tissues
26
, 
here we pinpoint reactions that are involved in the development of cancer. We obtain similar 
results when extending the analysis to include cancer associated genes from high-throughput 
mutational screenings, whole-exome and whole-genome sequencing
27
 (hypergeometric test, 
p-value=9.6·10
–4
, see Methods). 
We hypothesize that those reactions that are critical drivers in networks of cancer 
metabolism but are redundant in the corresponding healthy tissue play key roles in tumor 
development. We refer to these reactions as metabolic switches because of their divergent 
role in controlling cancer, but not healthy metabolism. In total, there are 21 metabolic 
switches (Supplementary Table 2). The number of couplings of metabolic switches differs 
between the cancer and healthy tissue networks, mostly with respect to inhibitive couplings 
(Supplementary Fig. 6). Specifically, the lower frequency of inhibitive couplings in cancer 
compared to eukaryote metabolism (cf. Fig. 2) is also observed in metabolic switches. This 
suggests that the less extensive competition between pathways in cancer cells may be an 
important feature of their (de)regulation.  
We focus on metabolic switches across cancer types, i.e. reactions which are critical 
drivers in more than one cancer type and redundant in the corresponding healthy tissues. In 
total, we find five such reactions (Supplementary Table 2): (1) hydrolysis of S-
adenosylhomocysteine (SAH) by SAH hydrolase (EC 3.3.1.1); (2) phosphorylation of 
deoxyguanosine by deoxyguanosine kinase (dGK, EC 2.7.1.113); (3) phosphorylation of 
diacylglycerol (DAG) to phosphatidic acid (PA) by diacylglycerol kinase (DAGK, EC 
2.7.1.107); (4) oxygenation of inosine monophosphate (IMP) by IMP dehydrogenase (EC 
1.1.1.205); (5) phosphorylation of deoxyadenosine by deoxyadenosine kinase (dAK, EC 
2.7.1.76). Indeed, four of these reactions are widely known to be involved in key aspects of 
cancer regulation. First, SAH hydrolase is essential for maintaining low levels of SAH in 
healthy cells, as varying levels of SAH can lead to DNA hypomethylation
28,29
 and cancer
30-34
. 
Its inhibition by different drugs selectively induces apoptosis in cancer, but not in healthy 
cells
35-39
, confirming its predicted role as critical driver in cancer, but not in healthy tissues. 
Second, high level of dGK is associated with leukemia
40
, and its phosphorylation of several 
nucleoside analogues increases sensitivity to these anticancer drugs
41-43
. Third, DAGKs are 
enzymes catalyzing a key step of the phosphatidylinositol cycle, acting as a molecular switch 
between cell signaling and lipid metabolism
44
. Their activation is essential for invasiveness, 
mitogenesis and growth of various cancer types
45-47
. Elevated levels of DAGKs are 
associated with malignant transformation
44
, and the product PA activates the cancer 
associated mTOR signaling pathway
48
. Fourth, IMP dehydrogenase has a central role in 
developing cancers from adult stem cells
49
 and is widely used as therapeutic target for a range 
of cancer types
50-52
. Importantly, each of these enzymes has multiple roles in cancer 
signaling, gene regulation, and metabolism
36,41,48,51
, suggesting that metabolic switches play 
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key roles in regulation of cancer metabolism at the interface with other cellular functions. 
While the specific role of dAK in cancer is less evident, its substrate deoxyadenosine was 
found to be involved in leukemia
53,54
, and the same reaction is also catalyzed by dGK and 
deoxycytidine kinase, which are known to be involved in tumor development
40,55
. It is also 
tightly linked to SAH metabolism and DNA methylation
56
. Our results therefore indicate that 
deoxyadenosine phosphorylation is also central to tumor development and may be used as a 
novel therapeutic target. 
Importantly, our method also helps us reveal the molecular causes for the (de)regulation 
of metabolic pathways. For example, we find that SAH hydrolase is fully coupled to 
methyltransferase in the healthy glandular breast and urothelial networks, indicating that the 
production of SAH, a byproduct of essential methylation reactions, is coupled to its 
degradation by SAH hydrolase (Fig. 5a, b). Indeed, the tight coupling of SAH production by 
methylation reactions to its degradation by SAH hydrolase is necessary to avoid the 
inhibition of essential methyltransferases, and thus hypomethylation, because SAH strongly 
inhibits methyltransferases
28,29
. In the metabolic networks of the corresponding cancer types 
(i.e. breast and urothelial cancer), we find that the SAH hydrolase and methyltransferase 
reactions are not fully but inhibitively coupled due to the common production of SAH (since 
SAH hydrolysis is reversible) (Fig. 5c). This result suggests that SAH levels are no longer 
controlled by SAH hydrolase activity in these cancers. Instead, the inhibitive coupling from 
the reversed SAH hydrolase reaction to methyltransferase indicates that a large flux toward 
the production of SAH may inhibit methylation in cancer, which is in agreement with the 
experimental studies
28,34
. 
Methods 
Analyzed metabolic networks. We analyze 23 metabolic networks encompassing a broad 
spectrum of organisms from all kingdoms of life, including genome-scale networks and 
subsystems, condition- and tissue-specific, healthy, and cancer networks. The covered 
organisms include three archaea
57-59
, five prokaryotes
12,60-63
, and five eukaryotes
17,64-67
. 
The represented subsystems include three networks of central metabolism
5,66,68
, four 
human tissue-specific networks and four cancer networks associated to these tissues
69
. The 
number of subcellular compartments ranges from one (in archaea, central metabolism of E. 
coli, M. pneumoniae, and M. tuberculosis) to seven in the H. sapiens genome-scale, tissue-
specific and cancer networks. The number of reactions capable of carrying steady-state flux 
in the analyzed networks ranges from 75 (for central metabolism of E. coli) to 2,719 (for 
glandular breast tissue). Details of the analyzed networks are provided in Table 1.  
Calculation of flux coupling relations. Full, partial, and directional coupling are calculated 
using the F2C2 tool
70
. To define anti-coupling, we restrict the set of feasible flux distributions 
to 
  {                           }, 
where n is the number of reactions, S the stoichiometric matrix, lb, ub the lower and 
upper flux bounds, and E the set of exchange reactions. Here, we use ub=1,000, lb=0 for 
irreversible, and lb=-1,000 for reversible reactions, since these values haven previously been 
used for similar constraints
71
. We point out that reaction couplings do not depend on the 
choice of (uniform) flux bounds (Supplementary Methods). To determine whether two 
reactions i and j are anti-coupled, i.e., vi=0 implies vj0 for each feasible flux distribution v, 
we determine the feasibility of a vector vF satisfying vi=0 and vj=0 using a mixed integer 
linear program (MILP). If no such vector exists, then the reactions i and j are anti-coupled. 
To determine whether a reaction i is inhibitively coupled to a reaction j, i.e., a maximum flux 
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of reaction i implies vj=0, we first determine the maximum flux of i, i
*
=maxvFvi, using flux 
variability analysis
72
. We then determine the feasibility of a vector vF satisfying vi=i
*
 and 
vj0 using a MILP. If no such vector exists, then i is inhibitively coupled to j. The MILPs for 
calculating full, partial, directional, anti- and inhibitive couplings are discussed in the 
Supplementary Methods.  
Clustering of flux coupling profiles. The flux coupling profile of a metabolic network S is 
given by a vector ϕ 5 representing the normalized frequencies of the five coupling types: 
  ( )  
    
∑     
 
   
        , 
where      is the number of reaction pairs coupled by type i. We apply three classical 
clustering algorithms, i.e., hierarchical (agglomerative), k-means, and k-medoids, based on 
the Euclidean distances of the flux coupling profiles from the 23 analyzed networks. We 
evaluate the clusters obtained at each cutoff distance (hierarchical clustering) and for each 
possible number of clusters (k-means and k-medoids) using the Silhouette, Calinski-
Harbasz
73
, and Davies-Bouldin
74
 indices. For a given clustering C={C(1), ..., C(k)} of our 
n=23 networks, the Silhouette index is given by 
  ( )  
 
 
∑
         
   {         }
 
   
  
where bcdi is the smallest average of the Euclidean distances of a profile i to the profiles in 
all other clusters, and wcdi is the average Euclidean distance of profile i to all profiles within 
the same cluster. Thus, SI(C)[-1,1], with larger values indicating higher quality of the 
clustering. The Calinski-Harbasz index
73
 is defined as 
  ( )     ( )
   ( )
   
   
   
, 
where bcv(C) is the between-cluster variance, and wcv(C) is the within-cluster variance. 
Thus, CH(C)≥0, where larger values indicate higher quality of the clustering. The Davies-
Bouldin index
74
 is given by 
  ( )  
 
 
∑       {
         
     
}   , 
where wcci is the average Euclidean distance between each profile in cluster i and the 
centroid of cluster i, wccj is the average distance of each profile in cluster i and the centroid 
of cluster j, and cdi,j is the distance between the centroids of clusters i and j. Thus, DB(C)≥0, 
where small values indicate a high quality of the clustering.   
When applying the three clustering algorithms to the flux coupling profiles obtained from 
the complete set of coupling types, we obtain the same clustering from each algorithm only 
for k=5 clusters, which corresponds to a cutoff distance of 0.25. The clustering and quality for 
all other cutoffs differ depending on the selected algorithm and quality measure. For k=5, we 
obtain SI(C)=0.66, CH(C)=30.0, and DB(C)=0.7 (cf. Fig. 2a). The highest cluster qualities 
are obtained for k=20 (using the Calinski-Harbasz index with k-medoids or k-means 
clustering) and k=22 (all other combinations), corresponding to only 1 or 3 non-singleton 
clusters formed by 2 networks each. This indicates a strong separation of most networks by 
their flux coupling profiles. The non-singleton cluster for k=22 is formed by the two non-
extremophile archaea, while k=20 yields two additional clusters formed by the healthy 
glandular breast and lung tissue networks, and the healthy urothelial and kidney tissue 
networks, respectively. Each of these clusters is a subset of, and thus in agreement with, the 
clusters obtained for k=5. 
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When considering only the previously studied flux coupling types, i.e., full, partial, and 
directional coupling, the three clustering algorithms give a consistent clustering for k=14 and 
k=21, corresponding to cutoff distances of 0.075 and 0.033, respectively. These sets of 
clusters, as well as the clusters for k=5, differ significantly from the five clusters obtained 
from the complete set of flux coupling profiles (adjusted Rand Index
75
 of 0.14 for k=5, 
6.1·10
-14
 for k=14, and 0.01 for k=21, respectively). Moreover, we do not observe 
phylogenetic or functional relationships in these clusters (cf. Results and Supplementary 
Fig. 3). 
To determine whether the clustering of flux coupling profiles based on the complete set 
of coupling types is a consequence of structural determinants, we employ the same clustering 
approach to the normalized cumulative singular value spectra of the metabolic networks
17
. 
The singular values of a stoichiometric matrix S are given by the diagonal entries of D 
obtained by singular value decomposition: 
      . 
The cumulative singular value spectra are obtained from the singular values by dividing the 
cumulative values of Di,i by the sum of singular values ∑      . Clustering of the cumulative 
singular value spectra yields only one set of clusters that is consistent across the clustering 
methods: A. thaliana and the genome-scale network of H. sapiens form two singleton 
clusters, while all remaining networks fall into the same cluster at a cut-off distance of 0.97, 
yielding SI(C)=0.98, CH(C)=211.6, and DB(C)=0.07. When comparing these clusters to 
those obtained from the flux coupling profiles, we obtain an adjusted Rand Index of -0.06, 
indicating a significant dissimilarity. 
Biochemically feasible network randomization and p-values. To test the hypothesis that 
the flux coupling profiles of the analyzed metabolic networks reflect functionally important 
features of metabolism, we determine their statistical significance using network 
randomization under mass-balance constraints
14
. The reactions of a metabolic network are 
randomized by replacing their substrates and products by compounds from the same network 
and changing their stoichiometric coefficients, while preserving atomic mass balance. The 
resulting randomized networks satisfy basic physical principles, allowing us to estimate the 
significance of network properties in a biological context
15
. We calculate the flux coupling 
profile of each randomized network and determine z-scores 
   
(     )
  
, 
where xi=ϕi(S) is the relative frequency of coupling type i in the network S,    is the average 
frequency of coupling type i over randomized networks, and  i its standard deviation. The p-
values are given by 
    ∫  (   )
 
    
. 
We find that the frequencies of directional, full, and inhibitive couplings differ 
significantly from random networks in 16, 18, and 19 of the 23 real-world networks, 
respectively (z-score based p-values 0.05) suggesting that these couplings are a result of 
functional or evolutionary constraints
15
. The relative frequencies of partial couplings are not 
significant in any of the considered networks, while the relative frequencies of anti-couplings 
are significant only for the network of M. pneumoniae. The latter also contains the largest 
number of significant coupling types (i.e., full, directional, anti, inhibitive), followed by 15 
networks with three significant coupling types (i.e., full, directional, inhibitive). The profiles 
of A. thaliana, T. maritima, M. barkeri, and M. acetivorans do not contain significant 
coupling types, although the p-values of inhibitive coupling in the latter two are close to the 
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used significance level (0.0545 and 0.057, see Supplementary Table 1). Altogether, these 
findings suggest that the flux coupling profiles for most of the networks reflect functional or 
evolutionary features of the considered metabolic pathways
15
.  
Sampling of reaction activity patterns. Since the commonly employed methods for random 
sampling of steady-state flux distributions generate non-zero flux values, rather than a 
random distribution of active and inactive reactions, they are not suitable for our approach. 
Therefore, here we develop two different schemes for random sampling of steady-state 
feasible reaction activity patterns. In the first scheme, each import reaction is specified as 
inactive with probability 1/2. Next, a feasible flux distribution vF is calculated by 
maximizing the fluxes of export reactions with randomly chosen coefficients. This approach 
corresponds to specifying a random set of available nutrients while maximizing diverse 
combinations of export fluxes, and aims at generating diverse and biologically meaningful 
reaction activity patterns. The steady-state compatible activity pattern of the sample is given 
by the support of the generated flux vector, =|sign(v)|. 
The second scheme generates an initial feasible reaction activity pattern 1 by 
minimizing    (     ), such that vF with 1=|sign(v)|, where d1 is a random vector in 
[-1, 1]
n
.  A subsequent sample i is generated by minimizing    (     ), where      
 ∑   (   )
   
    is the sign inversed mean of all previous samples, normalized to [-1,1]. 
Again, the feasibility of i is achieved by satisfying the existence of vF with i=|sign(v)|. 
This scheme aims at sampling maximally distinct activity patterns. Again, the feasible 
activity pattern of the sample is given by =|sign(v)|. The obtained results based on 500, 
1,000, or 5,000 activity patterns are virtually identical for each of the two sampling schemes. 
Flux coupling graph. The flux coupling graph (FCG) of a metabolic network is a directed 
labeled graph G=(V,E), where V is the set of all unblocked, non-essential reactions of the 
network, and two vertices i, j are connected by an edge (i,j)E, if reaction i is coupled to 
reaction j. Five edge labels L={full, partial, directional, anti, inhibitive} indicate that i is coupled 
to j by the corresponding coupling type. Note that edges with labels full, partial, anti are 
symmetric: if (i,j)E and L(i,j){full, partial, anti}, then (j,i)E with L(i,j)=L(j,i). Moreover, 
the edges of type full, partial, and directional reflect the transitivity of the respective couplings: 
if (i,j), (j, k)E, L(i,j)=L(j,k){full, partial, directional}, then (i,k)E, L(i,j)=L(j,k)=L(i,j). We 
show that calculation of the driver reactions in large networks is computationally inexpensive 
due to the transitivity relations (Supplementary Discussion). For a given reaction activity 
pattern, we use the flux coupling graph to generate the control graph and calculate the driver 
reactions. 
Control graph. For a metabolic network with n reactions, a given reaction activity pattern 
={0,1}n specifies the active reactions 1={i: i=1} and inactive reactions 
0
={j: j=0}, 
where |10|=n and 10=. The steady-state feasibility of activity patterns, i.e., vF 
with |sign(v)|=, is guaranteed by our sampling approach (see Sampling of reaction activity 
patterns). To determine the driver reactions for , we first generate the control graph (CG), 
which contains a vertex for each reaction i, and a directed edge (i→j), if i and j are coupled, 
and controlling the status of reaction i allows us to impose the status of reaction j specified by 
. Formally, the edges in the CG are specified by the adjacency matrix M, where Mi,j=1, if 
either of the following hold: 
(1) i=j=1 and L(i,j){full, partial, directional}, or 
(2) i=0, j=1, and L(i,j)=anti, or 
(3) i=1, j=0, and L(i,j){inhibitive}, or 
(4) i=j=0 and L(i,j){full, partial}, or 
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(5) i=j=0 and L(j,i)=directional, 
and Mi,j=0 otherwise. 
Calculation of driver reactions. The driver reactions are given by a smallest set of reactions, 
whose activities must be specified to activate all reactions in 1 and deactivate all reactions in 
0. In the CG, the driver reactions D(CG) correspond to a minimum out-dominating set19, i.e., 
a smallest set D⊆V(CG), such that D N+(D)=V(CG), where N+(D) is the first-order out-
neighborhood of D. We determine the driver reactions from the adjacency matrix M of the 
control graph using the following integer linear program: 
   ∑  
 
   
 
          , 
where x{0, 1}n. The solution yields x with a minimal number of non-zero entries and 
x·M≥1. Thus, each reaction i with xi=1 is in a minimum out-dominating set of the CG, and 
corresponds to a driver reaction of . 
Transcriptional regulation of E. coli metabolism. To determine the agreement between 
coupled reactions and their co-regulation, i.e., regulation of genes by a common transcription 
factor (TF), we obtain the genes associated to the enzymes in the genome-scale metabolic 
network of E. coli from the Supplementary Material of Orth, et al.
12
 and KEGG
76
. This 
results in 925 enzymatic reactions (and, hence, 427,350 reaction pairs), of which 24 are 
involved in transport of protons or molecules across the inner membrane: ATP synthase, fatty 
acid-coenzyme A ligase (involving 10 different fatty acids), formate dehydrogenase 
(oxidation of either ubiquinone or menaquinone-8), hydrogenase (hydrogenation of 
ubiquinone, menaquinone-8, or 2-Demethylmenaquinone), NADH dehydrogenase (oxidation 
of ubiquinone, menaquinone-8, or 2-Demethylmenaquinol-8), glycohydrolase catalyzed 
cytosolic import of nicotinamide, nitrate reductase (reduction of ubiquinol in the cytosol or 
periplasm and reduction of 2-Demethylmenaquinol-8), and NAD(P)
+
 transhydrogenase. Next, 
we obtain the transcriptional regulatory network from RegulonDB
11
, and determine the TFs 
regulating (i.e., activating or repressing) the genes of the 925 enzymatic reactions of E. coli. 
Two reactions are co-regulated, if there is at least one TF activating or repressing any of the 
genes associated to both reactions (cf. Supplementary Fig. 2). The number of TFs regulating 
a reaction is then given by the number of unique TFs activating or repressing the genes that 
encode its catalyzing enzymes (cf. Fig. 4). Similar results are obtained when extending the 
analysis to include genes regulated by small RNAs.  
Driver reactions in cancer. We analyze four cancer networks (i.e., breast, lung, renal, and 
urothelial cancer) and networks of the corresponding healthy tissues (glandular breast, 
pneumocytes, kidney, and urothelial cells)
69
. To determine the reactions which are associated 
to genes known to cause cancer, we obtain 547 census genes from the Catalogue of somatic 
mutations in cancer (COSMIC)
25
 and additional 1,453 genes from high-throughput 
mutational screenings, whole-exome sequencing, and whole-genome sequencing of cancer 
samples from the Network of Cancer Genes (NCG)
27
 (March 2015 database versions). Next, 
we map the reactions to genes through their gene-enzyme-reaction relationship (which 
excludes non-enzymatic reactions, such as transport and diffusion reactions), yielding a total 
of 2,363 reactions from the four cancer networks. Of these, 112 are associated to cancer 
causing genes from COSMIC (4.7%), and 614 to genes from the NCG dataset (26.0%). We 
identify 620 reactions as critical drivers in any of the four cancer networks (26.2%). Out of 
these, 45 are associated to the census genes in COSMIC (7.3%) and 191 to genes from the 
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NCG dataset (30.8%), yielding p-values of 6.8·10
-4
 (COSMIC) and 9.6·10
-4
 (NCG) 
(hypergeometric test) for the overrepresentation of these genes. 
To identify reactions which may have a key role in (de)regulation of cancer metabolism 
and tumor development, we focus on reactions which are critical drivers in cancer networks 
and redundant in the corresponding healthy tissues (metabolic switches). There is no reaction 
which is a metabolic switch for each of the four cancer types. Diacylglycerol kinase is the 
only metabolic switch for three cancer types (lung, urothelial, and renal). Four reactions are 
metabolic switches for two cancer types: S-adenosylhomocysteine hydrolase (urothelial and 
breast), deoxyguanosine kinase (urothelial and renal), IMP dehydrogenase (urothelial and 
breast), and deoxyadenosine kinase (renal and breast). Diacylglycerol kinase, S-
adenosylhomocysteine hydrolase, deoxyguanosine kinase, and IMP dehydrogenase play key 
roles in tumor development, and there is some support for the role of deoxyadenosine kinase 
in cancer (see Results and Supplementary Table 2). 
Discussion 
We propose a computational framework to study the flux control of metabolic networks, 
which combines the computational efficiency of biased methods with the comprehensiveness 
of unbiased approaches. By formalizing the requirement of biological systems to exchange 
matter with the environment we are able to introduce two new coupling relations: anti-
coupling, representing the combined essentiality of two reactions for each possible steady-
state, and inhibitive coupling, representing the competition of reactions for common 
substrates/products. Since the presence of anti-coupling indicates condensed rather than 
redundant pathways, the concept may stimulate further analyses in smaller subsystems of 
metabolism. The obtained complete set of coupling relations covers each possibility of 
(de)activating a reaction by controlling active/inactive reactions to which it is coupled. The 
clustering of 23 metabolic networks from diverse biological contexts by their flux coupling 
profiles reflects phylogenetically and functionally distinct groups, and distinguishes healthy 
tissues from cancer cells. This indicates that the flux coupling profiles could be used as 
descriptors for characterization of system-dependent metabolic requirements beyond the 
universal structural features of metabolic networks
77
.  
By using an analogy to a classical graph-theoretic problem, we determine the smallest 
sets of reactions that must be directly controlled to achieve a feasible reaction activity pattern 
at steady state. We find that critical and intermittent driver reactions are under strong 
transcriptional regulation in the metabolic network of E. coli, indicating that cellular 
regulation relies on driver reactions to achieve efficient control of metabolism. This serves as 
a proof-of-concept of our optimality-based framework. By employing metabolic networks of 
four cancer types and their corresponding healthy tissues, our method predicts driver 
reactions for controlling tumor development, many of which indeed have known causal roles 
in cancer. We find that reactions acting as metabolic switches for more than one cancer type 
are key control points of tumor development and have direct interactions with multiple 
cellular levels, supporting the view that tumor development is controlled at the interface of 
gene regulation, signaling, and metabolism. Driver reactions whose role in cancer is yet 
unknown may serve as starting point for identifying novel therapeutic targets. Importantly, 
the (bio-)chemical basis of our approach facilitates insights into the molecular mechanisms of 
control, such as the inhibition of methyltransferases by the modified coupling relations of 
SAH hydrolase in breast and urothelial cancer (cf. Fig. 5). Hence, our framework can be used 
to gain mechanistic insights into cellular regulation in disease and engineering of biological 
systems. 
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Figure 1 | Illustration of flux coupling graph, control graph, and driver reactions. (a) 
Left: Metabolic network with vertices representing metabolites, labeled A-F, hyper-edges 
representing internal reactions, labeled R1-R5, and exchange reactions, labeled E1-E4. Right: 
Flux coupling graph of the internal reactions of the metabolic network, with vertices 
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representing reactions, and labeled edges representing the five coupling relations (represented 
by different colors, see legend). Here, only internal reactions are considered for brevity 
(Supplementary Fig. 1 shows the flux coupling graph including exchange reactions). (b)-(d) 
Three activity patterns (left) describing the active (black arrows) and inactive reactions (gray 
arrows). The control graphs (right) are obtained by integrating the flux coupling graph with 
the activity pattern, and describe which reactions can be controlled to impose the status of 
other reactions in the activity pattern (see Methods). The driver reactions are given by a 
smallest set of vertices, such that each vertex in the control graph is either contained in the set 
or a direct successor of a vertex from the set. Vertices corresponding to driver reactions are 
colored; one vertex of each color must be controlled simultaneously. The required activities 
of the driver reactions (deactivation, activation, or maximization) are depicted next to the 
vertices. For example, activity pattern 1 is achieved by the simultaneous activation of R1 and 
deactivation of either R4 or R5. 
 
Figure 2 | Clustering of flux coupling profiles. (a) Top: Silhouette index over number of 
clusters for three clustering methods: hierarchical, k-means and k-medoids. For 5 clusters 
(dashed line) the three methods give identical clustering (blue, red, and green circles), which 
is shown in (b)-(f). Bottom: Cluster dendrogram obtained from hierarchical clustering of the 
flux coupling profiles using Euclidean distances. (b) Cluster 1 contains the flux coupling 
profiles of both non-extremophile archaea. (c) Cluster 2 combines the flux coupling profiles 
of organisms adapted to extreme environmental conditions: the haloalkaliphilic N. pharaonis, 
the hyper-thermophilic T. maritima, the solvent tolerant P. putida, as well as the pathogen M. 
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pneumoniae and urothelial cancer. (d) Cluster 3 contains the flux coupling profiles of both 
networks representing E. coli central metabolism. (e) Cluster 4 combines the genome-scale 
networks of E. coli, M. tuberculosis, and three of the four cancer networks. (f) Cluster 5 
contains all analyzed eukaryotic networks, including the fungi A. niger, unicellular algae C. 
reinhardtii, H. sapiens, M. musculus, and the four tissue-specific human networks. 
 
a
b
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Figure 3 | Flux control properties of the 23 analyzed metabolic networks. (a) 
Relationship between network size (x-axis) and complexity of flux control, as quantified by 
the fraction of driver reactions required for controlling all reactions (y-axis). Three groups 
can be distinguished: complex control of small central metabolic networks (triangles), easy 
control of the medium sized, predominantly microbial networks (squares), and intermediately 
complex control of the large E. coli, human and cancer networks (circles). (b) Relationship 
between flux coupling and complexity of flux control. Networks arranged by the fraction of 
coupled reaction pairs (x-axis) and fraction of driver reactions required for controlling all 
reactions (y-axis). The fraction of driver reactions decays logarithmically (scaling coefficient 
of 0.24, dashed line) with the fraction of coupled reactions, indicated by a Pearson correlation 
of –0.72 on the log-log data (inset). The legend is sorted by decreasing fraction of driver 
reactions required for control of the network. 
 
Figure 4 | Transcriptional regulation of reaction classes in E. coli. (a) Box plot of the 
number of transcription factors regulating redundant, intermittent, and critical reactions, 
indicating the median (red lines), 25th and 75th percentiles (blue boxes), maximum non-
outlier value (black whiskers), and outliers (red crosses). (b) Venn diagram showing the 
number of transcription factors associated with redundant, intermittent, and critical reactions, 
and their intersections. 
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Figure 5 | Control of methylation by the SAH hydrolase driver reaction. (a) Central 
reactions of the methionine cycle, essential for methylation of DNA, RNA, and proteins. 
SAH hydrolase is identified by our method as metabolic switch for urothelial and breast 
cancer. It controls methylation by regulating the level of produced SAH, which inhibits 
methyltransferases. (b) Flux coupling graph of the reactions from (a) in healthy breast tissue. 
Full coupling between SAH hydrolase and methyltransferase ensures that SAH is produced 
and consumed at equal rates, avoiding its accumulation and DNA hypomethylation. (c) Flux 
coupling graph of the reactions from (a) in the breast cancer network. SAH hydrolase is no 
longer fully coupled to methyltransferase and methionine synthase, allowing for independent 
fluxes of the reactions and varying SAH levels. Inhibitive coupling between SAH hydrolase 
and methyltransferase implies that elevated flux of either reaction inhibits flux of the other 
reaction due to accumulation of the common product SAH, leading to DNA hypomethylation 
and cancer, which is in agreement with experimental findings (Results). Abbreviations: Ado, 
Adenosine; Hcy, Homocysteine; L-Met, L-Methionine; SAH, S-adenosylhomocysteine; 
SAHH, SAH hydrolase; SAM, S-adenosylmethionine; SAMS, SAM synthase; MetS, 
methionine synthase; MT, methyltransferase. 
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Table 1 | Metabolic networks analyzed in the paper. For each network, we show its cluster 
(C; cf. Fig. 2), network name, number of (unblocked) reactions (n), percent of driver 
reactions (d), brief description, and reference. 
C Network n d Description Ref. 
1 
M acetivorans iMB745 628 18.3 
Genome-scale metabolic network 
of Methanosarcina acetivorans 
58 
M barkeri iAF692 537 16.7 
Genome-scale metabolic network 
of Methanosarcina barkeri 
59 
2 
N pharaonis 601 46.3 
Genome-scale metabolic network 
of Natronomonas pharaonis 
57 
T maritima 460 15.5 
Core metabolism of Thermotoga 
maritima 
60 
P putida iJN746 912 24.5 
Genome-scale metabolic network 
of Pseudomonas putida KT2440 
61 
iUrothelialCancer1647 2,302 39.9 
Metabolic network of urothelial 
cancer cells 
69 
M pneumoniae iJW145 239 43.4 
Genome-scale metabolic network 
of Mycoplasma pneumoniae 
62 
3 
Ecoli Carbon 98 81.6 
Carbon metabolism of Escherichia 
coli 
5 
Ecoli Core 75 69.7 
Central metabolism of Escherichia 
coli 
68 
4 
Ec iJO1366 2,371 29.7 
Genome-scale metabolic network 
of Escherichia coli 
12 
M tuberculosis iNJ661 800 31.1 
Genome-scale metabolic network 
of Mycobacterium tuberculosis 
H37Rv 
63 
iBreastCancer1771 2,288 38.9 
Metabolic network of breast cancer 
cells 
69 
iLungCancer1472 2,065 36.1 
Metabolic network of lung cancer 
cells 
69 
iRenalCancer1410 2,186 35.1 
Metabolic network of renal cancer 
cells 
69 
5 
A niger 1,018 44.1 
Genome-scale metabolic network 
of Aspergillus niger 
64 
ArabidopsisCoreModel auto 494 21.4 
Core metabolism of Arabidopsis 
thaliana under autotrophic day 
conditions 
65 
C reinhardtii iAM303 206 57.9 
Central metabolism of 
Chlamydomonas reinhardtii 
66 
H sapiens recon1 2,042 49.2 
Genome-scale metabolic network 
of Homo sapiens 
17 
M musculus 859 35.8 
Genome-scale metabolic network 
of Mus musculus 
67 
BreastHealthy 2,719 45.6 
Metabolic network of human 
glandular breast cells 
69 
LungHealthy 2,343 39.9 
Metabolic network of human 
pneumocytes 
69 
KidneyHealthy 2,662 37.1 Metabolic network of human 69 
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kidney cells 
UrothelialHealthy 2,430 36.6 
Metabolic network of human 
urothelial cells 
69 
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